PCOS is Now Called PMOS: Recognizing Metabolic Health at the Core of This Condition

PCOS has been officially renamed PMOS. Learn what the change means for women's health, why insulin resistance is central, and how a metabolic approach can help.

Georgia Chen

If you've been living with PCOS, or suspect you might have it, you've likely felt the frustration of a condition that touches so many parts of your health at once: weight that won't move, blood sugar swings, irregular cycles, energy crashes. And perhaps a sense that no doctor or treatment was ever looking at the full picture.

This past week, the medical world acknowledged the systemic nature of this condition.

More than 50 global organizations have officially renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). Published in The Lancet, the new name reflects input from over 14,000 patients with PCOS and multidisciplinary health professionals worldwide.


What’s in a name?

You might be thinking, Why does one letter matter so much?

The old name centred on ovarian cysts, but cysts were never actually a defining feature of the condition. That misdirection led to missed diagnoses, fragmented care, and a systemic failure to address what was really happening: a complex hormonal and metabolic disorder driven largely by insulin resistance. By acknowledging the true nature of the disorder, this new name shifts the conversation toward better awareness and understanding, and could help women living with the condition receive earlier diagnosis and more comprehensive care.

PMOS puts the right words front and center. Polyendocrine indicates that multiple hormone systems are involved. Metabolic reflects that this is a metabolic condition, not just a reproductive one. Ovarian acknowledges that the ovaries are affected, but they're not the whole story.


Insulin resistance is at the core of PMOS

Insulin resistance isn't just a side effect. It can be a central driver of the condition, which is now better reflected by including the word Metabolic in the name. It disrupts hormonal signalling, makes weight loss significantly harder, and raises long-term risk for metabolic syndrome, type 2 diabetes, and cardiovascular disease. Yet for years, treatment focused on managing individual symptoms rather than the underlying metabolic dysfunction.

That's where nutrition-based intervention makes a real difference.

A structured, low-glycemic approach to eating—one that reduces glucose load, stabilizes insulin levels, and supports hormonal balance—directly targets the metabolic environment that PMOS thrives in. This isn't about eating less. It's about eating in a way that works with your metabolism instead of against it.


Ideal Protein has been built on this understanding from day one

The Ideal Protein Protocol is a medically developed ketogenic weight loss program designed to address the root causes of insulin resistance and metabolic dysfunction, not just the number on the scale. Renaming PCOS as PMOS validates what Ideal Protein has always understood: weight, hormones, and metabolism are inseparable. Treating one without addressing the others will always fall short.

You deserve an approach that treats the cause, not just the symptoms.

If you're living with PMOS and looking for nutritional support grounded in metabolic science, we're here to help. Fill out this health profile form to get connected with an Ideal Protein clinic near you. Take the first step toward a structured metabolic reset built specifically for how your body works.

Related reads for you

Discover more articles that align with your interests and keep exploring.

Announcement

What We Learned at Super Weekend 2026

What does metabolic health actually look like in 2026? From glycation and GLP-1 medications to Zone 2 training, menopause metabolism, and Type 2 diabetes remission — here are the 10 biggest weight loss insights from Ideal Protein's Super Weekend 2026 conference.

Science

Weight Loss in a Pill? What You Need to Know About Foundayo

The FDA just approved Foundayo, Eli Lilly's new once-daily GLP-1 weight loss pill — but does appetite suppression alone lead to lasting results? Learn what the latest research says about muscle loss, nutritional deficiencies, and why a structured approach to weight management matters more than ever.

Science

Why Glycation May Be the Missing Link in Long-Term Weight Management

Understanding Glycation: Membrane Integrity, Metabolism, and the Role of Ketosis. Protein glycation and its role in insulin resistance.

Announcement

What We Learned at Super Weekend 2026

What does metabolic health actually look like in 2026? From glycation and GLP-1 medications to Zone 2 training, menopause metabolism, and Type 2 diabetes remission — here are the 10 biggest weight loss insights from Ideal Protein's Super Weekend 2026 conference.

Science

Weight Loss in a Pill? What You Need to Know About Foundayo

The FDA just approved Foundayo, Eli Lilly's new once-daily GLP-1 weight loss pill — but does appetite suppression alone lead to lasting results? Learn what the latest research says about muscle loss, nutritional deficiencies, and why a structured approach to weight management matters more than ever.